References
- YuWBRaoAVuVXuLRaoJYWuJXManagement of centrally located hepatocellular carcinoma: update 2016World J Hepatol201791362763428539990
- CarrBIHepatocellular carcinoma: current management and future trendsGastroenterology20041275 Suppl 1S218S22415508087
- LlovetJMUpdated treatment approach to hepatocellular carcinomaJ Gastroenterol200540322523515830281
- SchoenbergMBBucherJNVaterAResection or transplant in early hepatocellular carcinomaDtsch Arztebl Int201711431–3251952628835324
- WalkerMGZ39Ig is co-expressed with activated macrophage genesBiochim Biophys Acta20021574338739011997108
- AhnJHLeeYJeonCIdentification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysisBlood200210051742175412176896
- HelmyKYKatschkeKJGorganiNNCRIg: a macrophage complement receptor required for phagocytosis of circulating pathogensCell2006124591592716530040
- VogtLSchmitzNKurrerMOVSIG4, a B7 family-related protein, is a negative regulator of T cell activationJ Clin Invest2006116102817282617016562
- LiaoYGuoSChenYVSIG4 expression on macrophages facilitates lung cancer developmentLab Invest201494770671524862966
- SturtzLADeyarminBvan LaarRGene expression differences in adipose tissue associated with breast tumorigenesisAdipocyte20143210711424719783
- ByunJMJeongDHChoiIHThe significance of VSIG4 expression in ovarian cancerInt J Gynecol Cancer201727587287828498255
- XuTJiangYYanYVSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patientsAm J Transl Res2015761172118026279760
- RohJJeonYLeeANThe immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myelomaOncotarget2017835581225813228938542
- JungKKangMParkCProtective role of V-set and immunoglobulin domain-containing 4 expressed on Kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cellsHepatology20125651838184822711680
- LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2–DDCT methodMethods200125440240811846609
- TibshiraniRThe lasso method for variable selection in the Cox modeStat Med19971643853959044528
- SegalMRDahlquistKDConklinBRRegression approaches for microarray data analysisJ Comput Biol200310696198014980020
- DingXXZhuQGZhangSMPrecision medicine for hepatocellular carcinoma: driver mutations and targeted therapyOncotarget2017833557155573028903454
- VogtLSchmitzNKurrerMOVSIG4, a B7 family-related protein, is a negative regulator of T cell activationJ Clin Invest2006116102817282617016562
- JungKKangMParkCProtective role of V-set and immunoglobulin domain-containing 4 expressed on Kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cellsHepatology20125651838184822711680
- ZhangWWangXWangYEffective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: results of a 10-year follow upMedicine (Baltimore)20179644e845429095292
- ZhangXLvLOuyangXAssociation of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infectionCancer Med2016592180218927418384
- HeBZhangHShiTA comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesisPLoS One201164e1851621526182